A Thesis submitted to The University of Arizona College of Medicine - Phoenix in partial fulfillment of the requirements for the Degree of Doctor of Medicine.

No description available.

Submitted by JULIANA FERREIRA DE LIMA E ALMEIDA null (juli_lima@yahoo.com.br) on 2016-04-25T17:42:14Z No. of bitstreams: 1 Tese Doutorado.pdf: 2036000 bytes, checksum: b294f3567d825f2ab00ee13f4d023580 (MD5) / Approved for entry into archive by Felipe Augusto Arakaki (arakaki@reitoria.unesp.br) on 2016-04-27T11:45:47Z (GMT) No. of bitstreams: 1 lima_jf_dr_bot.pdf: 2036000 bytes, checksum: b294f3567d825f2ab00ee13f4d023580 (MD5) / Made available in DSpace on 2016-04-27T11:45:47Z (GMT). No. of bitstreams: 1 lima_jf_dr_bot.pdf: 2036000 bytes, checksum: b294f3567d825f2ab00ee13f4d023580 (MD5) Previous issue date: 2016-04-25 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) / A simpatectomia videotoracoscópica é o tratamento mais utilizado para pacientes com hiperidrose primária e o efeito colateral mais discutido é a sudorese reflexa. Contudo, os efeitos colaterais cronotrópicos e tardios são negligenciados e há discrepância de achados nos estudos que os avaliaram. Além disso, apesar de ser preconizada atualmente a abordagem do terceiro e quarto gânglios, todos os estudos encontrados na literatura endereçaram a abordagem do segundo e terceiro gânglios. Objetivo: Analisar o comportamento funcional cardiopulmonar no pós-operatório imediato, mediato e tardio de simpatectomia videotoracoscópica, bem como avaliar se a secção da cadeia simpática nos níveis de 3º e 4º gânglios torácicos interfere diretamente no desempenho em testes de exercícios cardiopulmonar, como o teste de caminhada de seis minutos e o teste de escada. Método: Testes de avaliação pulmonar, teste de caminhada de 6 minutos e o teste de escada foram realizados em 51 pacientes submetidos a simpatectomia videotoracoscópica, nos momentos do pré-operatório, primeiro dia, sétimo dia, trigésimo dia pós-operatórios e um ano após a cirurgia, bem como avaliação da dor e aplicação de escala de percepção de esforço de Borg. Resultados: A espirometria apresentou queda dos valores em torno de 50% no primeiro pós- operatório, permanecendo ainda abaixo dos valores normais até o sétimo pós- operatório. A manovacuometria apresentou queda de valores apenas no primeiro pós-operatório. Os testes de exercício mostraram alterações apenas no primeiro pós-operatório. Entretanto, a resposta cronotrópica, avaliada através da frequência de pulso ao repouso e após os testes de esforço, mostrou queda significativa logo no primeiro pós-operatório e queda gradual até a avaliação de um ano após o procedimento. Conclusão: A simpatectomia videotoracoscópica promove alterações imediatas na função cardiopulmonar que são mais pronunciadas até a 1ª semana, onde repercutem no pior desempenho durante os testes de esforço, mas desaparecem em até um mês após a cirurgia, sugerindo que as alterações mecânicas da videotoracoscopia sejam os fatores mais importantes para a queda dos parâmetros avaliados. Tardiamente há queda da frequência de pulso basal e da resposta cardíaca, após os testes de esforço, mas não no desempenho dos mesmos. Tais alterações podem ser atribuídas à desnervação simpática, mas não demonstraram repercussões clínicas na amostra avaliada. / The thoracoscopic sympathectomy is the most widely used treatment for patients with primary hyperhidrosis and the most discussed side effect is reflex sweating. However, chronotropic and late side effects are neglected and there is discrepancy findings in studies that evaluated it. Moreover, although currently recommended approach the third and fourth ganglia, all studies found in literature addressed the approach of the second and third ganglia. Objective: To assess cardiopulmonary performance in the immediate, mediate and late postoperative thoracoscopic sympathectomy period, as well as assess whether chain section to the levels of 3rd and 4th thoracic ganglia directly affects the performance on cardiopulmonary exercise testing, such as. Methods: Pulmonary evaluation tests, six minute walk test and stair climbing test were performed in 51 patients who underwent thoracoscopic sympathectomy in preoperative, first day, seventh day, thirtieth postoperative day and one year after surgery, as well as evaluation of pain and application of perceived Borg effort. Results: Spirometry showed a decrease of values around 50% in the first postoperative day, remaining still below normal values until the seventh postoperative day. The manovacuometry had reduced values only in the first postoperative day. Exercise tests showed alterations only in the first postoperative day. However, the chronotropic response as measured by pulse rate at rest and after stress tests showed significant drop right at the first postoperative day and gradually fall to the evaluation one year after the Conclusion: The thoracoscopic sympathectomy promotes procedure. immediate changes in cardiopulmonary function that are more pronounced until the 1st week, which have repercussions in the worst performance during the stress tests, but disappear within one month after surgery, suggesting that the videothoracoscopy mechanical changes is the most important factors for the fall of the evaluated parameters. Late there is a drop in baseline pulse frequency and pulse response after stress tests, but not in the performance thereof. Such changes can be attributed to sympathetic denervation, but showed no clinical repercussions in the sample investigated.

Orientador: Daniele Cristina Cataneo / Resumo: A simpatectomia videotoracoscópica é o tratamento mais utilizado para pacientes com hiperidrose primária e o efeito colateral mais discutido é a sudorese reflexa. Contudo, os efeitos colaterais cronotrópicos e tardios são negligenciados e há discrepância de achados nos estudos que os avaliaram. Além disso, apesar de ser preconizada atualmente a abordagem do terceiro e quarto gânglios, todos os estudos encontrados na literatura endereçaram a abordagem do segundo e terceiro gânglios. Objetivo: Analisar o comportamento funcional cardiopulmonar no pós-operatório imediato, mediato e tardio de simpatectomia videotoracoscópica, bem como avaliar se a secção da cadeia simpática nos níveis de 3º e 4º gânglios torácicos interfere diretamente no desempenho em testes de exercícios cardiopulmonar, como o teste de caminhada de seis minutos e o teste de escada. Método: Testes de avaliação pulmonar, teste de caminhada de 6 minutos e o teste de escada foram realizados em 51 pacientes submetidos a simpatectomia videotoracoscópica, nos momentos do pré-operatório, primeiro dia, sétimo dia, trigésimo dia pós-operatórios e um ano após a cirurgia, bem como avaliação da dor e aplicação de escala de percepção de esforço de Borg. Resultados: A espirometria apresentou queda dos valores em torno de 50% no primeiro pós- operatório, permanecendo ainda abaixo dos valores normais até o sétimo pós- operatório. A manovacuometria apresentou queda de valores apenas no primeiro pós-operatório. Os testes de... (Resumo completo, clicar acesso eletrônico abaixo) / Abstract: The thoracoscopic sympathectomy is the most widely used treatment for patients with primary hyperhidrosis and the most discussed side effect is reflex sweating. However, chronotropic and late side effects are neglected and there is discrepancy findings in studies that evaluated it. Moreover, although currently recommended approach the third and fourth ganglia, all studies found in literature addressed the approach of the second and third ganglia. Objective: To assess cardiopulmonary performance in the immediate, mediate and late postoperative thoracoscopic sympathectomy period, as well as assess whether chain section to the levels of 3rd and 4th thoracic ganglia directly affects the performance on cardiopulmonary exercise testing, such as. Methods: Pulmonary evaluation tests, six minute walk test and stair climbing test were performed in 51 patients who underwent thoracoscopic sympathectomy in preoperative, first day, seventh day, thirtieth postoperative day and one year after surgery, as well as evaluation of pain and application of perceived Borg effort. Results: Spirometry showed a decrease of values around 50% in the first postoperative day, remaining still below normal values until the seventh postoperative day. The manovacuometry had reduced values only in the first postoperative day. Exercise tests showed alterations only in the first postoperative day. However, the chronotropic response as measured by pulse rate at rest and after stress tests showed significant ... (Complete abstract click electronic access below) / Doutor

Abstract Interstitial lung diseases (ILD), including interstitial pneumonias (IP), represent disorders with variable degrees of parenchymal inflammation and/or fibrosis offer an ideal model to investigate the histopathological features in relation to the course of these diseases. The most common IP is idiopathic pulmonary fibrosis (IPF) with the histological pattern of usual interstitial pneumonia (UIP) exhibiting the histological hallmark of fibroblast foci (FF). Surgical lung biopsy (SLB) is not usually needed for diagnosis of IPF, but the lung biopsy samples taken by SLB confers the diagnosis in atypical cases. The safety of SLB in IPF/UIP has been a controversial issue. The acute exacerbation occasionally occurs during the course of IPF/UIP, but pathological features related to this event are poorly understood. Recent studies suggest that one important determinant in the pathogenesis of ILDs, as in IPF, is oxidant stress and an imbalance of the redox-state in the lung. Thiol containing redox-regulated proteins which paticipate in the antioxidant defence of the lung include thiorexin (Trx) and gamma-glutamylcysteine synthetase (γGCS), also called glutamate-cysteine ligase (GLCL), the rate-limiting enzyme of glutathione (GSH) synthesis. The goal of this research was to evaluate the safety of SLB and the relationships between the histological findings and the course of IPF/UIP, and to investigate the above mentioned defense mechanisms in a variety of ILDs by means of immmunohistochemical analyses, Western Blotting and immunoelectronmicroscopy. No deaths occurred in the following 30 days after 34 video-assisted thoracoscopic lung biopsy (VATS). The number of FF in the lung sample predicted the survival, but it was not associated with acute exacerbation of IPF/UIP before death. Diffuse alveolar damage was a common feature in autopsy samples. The studied redox regulated defense enzymes were expressed in bronchial epithelium, metaplastic alveolar epithelium and alveolar macrophages, but the fibrotic areas generally showed no expression. In IPF/UIP VATS is a safe diagnostic method and counting the number of FF represents a reproducible and reliable method for predicting patient survival. Alterations in the redox regulated defense enzymes further point to the importance of oxidant burden in the fibrotic lung.

PURPOSE: Hemothorax, the collection of blood in the intrapleural space, commonly arises in patients suffering from thoracic trauma. Fluid collections in this space can compromise cardiac and respiratory function and if left untreated, can result in hypovolemic crisis. Fluid is often successfully drained via a tube thoracostomy, in which an intercostal drain is inserted into the pleural space. If residual blood remains, however, clotting may occur and result in a retained hemothorax (RH). Intrapleural administration of tissue plasminogen activator (tPA), a fibrinolytic drug typically utilized in ischemic stroke, has been shown to be both a safe and effective technique to hydrolyze RH clots and reduce the need for more invasive surgical interventions. The present study aims to evaluate the safety and efficacy of tPA administration at Boston Medical Center (BMC) and compare this data to those of prior studies. This study will also investigate if tPA as a definitive treatment for RH, could reduce the need for additional interventions such as surgical procedures including Video-Assisted Thoracoscopic Surgery (VATS) and/or invasive thoracaotomy. Hospital/intensive care unit (ICU) lengths of stay (LOS), ventilator time, and complication rates will be used to determine if tPA may allow for a significant decrease in patient cost and burden of care versus surgery. An analysis of patient demographics and injury data will be used to determine the individual factors that could be used to predict the success of tPA as a definitive treatment. Using evidence-based treatment protocols, the aforementioned data will be critically evaluated to determine the appropriate timing and sequential positioning of tPA administration in the treatment algorithm for retained hemothorax. METHODS: A single-institution retrospective chart review was conducted of patients treated for traumatic pneumohemothorax by the Department of Acute Care and Trauma Surgery at Boston Medical Center. A study on predictive factors of the development of retained hemothorax included all such patients that presented to the emergency department (ED) between May 2014 and June 2016. Demographic and injury characteristics were analyzed to determine if patients from specific groups or with specific injuries are more prone to develop RH. To evaluate the safety of intrapleural tissue plasminogen activator, the incidence of complications such as post-trauma infection and mortality were determined in patients that were administered tPA to resolve retained hemothorax between May 2014 through December 2016. Next, utilizing an expanded data set, the efficacy of tPA was evaluated by determining the percentage of cases in which tPA was able to definitively resolve RH. Secondary efficacy data including average hospital length of stay, average ICU length of stay, average mechanical ventilation time, and rate of readmission were compared between various interventions as well. Finally, to elucidate the risk factors for RH and independent predictors of tPA as a definitive treatment, demographic data including age, ethnicity, and gender as well as injury data including mechanism of injury, the presence or absence of multisystem trauma, and the presence or absence of specific injuries such as rib fracture, pulmonary contusion, or diaphragmic insult were collected. RESULTS: A statistically significant positive correlation was observed between the likelihood of developing RH and both abdominal alimentary tract and extremity injuries, indicating that these injuries may serve as predictive factors for RH development. In a study investigating the safety of intrapleural tPA, there was no statistically significant difference in post-trauma infection rates between individuals treated with tPA and those who were not. Additionally, tPA treatment was associated with a lower mortality rate. Efficacy studies revealed that tPA therapy was associated with a statistically significant decrease in mechanical ventilation time, as compared to surgical intervention, however, tPA carried a RH resolution rate of just 43% with one patient experiencing a major adverse systemic reaction to the drug. Finally, demographic and injury data were analyzed to determine predictive factors of tPA success, but no statistically significant relationships were observed between any of these characteristics and the outcome of tPA therapy. CONCLUSION: Intrapleural tPA is a safe and effective alternative to more invasive surgical procedures. The success rate of tPA therapy in the present study was less than previous studies have indicated, however, the potential decreased ventilation time is important for preventing ventilator associated pneumonia (VAP) and the high rate of mortality it carries. Although the success rate is lower than expected, tPA should still be considered in the RH treatment protocol, prior to surgery, to decrease required ventilation time and potentially prevent the need for more invasive interventions with higher costs, morbidity, mortality rates, and patient burden.

京都大学 / 0048 / 新制・課程博士 / 博士(医学) / 甲第21338号 / 医博第4396号 / 新制||医||1031(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 坂井 義治, 教授 平井 豊博, 教授 溝脇 尚志 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

京都大学 / 0048 / 新制・課程博士 / 博士(医学) / 甲第21620号 / 医博第4426号 / 新制||医||1033(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 平井 豊博, 教授 宮本 享, 教授 福田 和彦 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

O tratamento cirúrgico do adenocarcinoma da junção esofagogástrica (AJEG) ainda é controverso, particularmente, em relação à sobrevida e complicações pós-operatórias. Com o advento da cirurgia minimamente invasiva e toracoscopia, houve um aumento da linfadenectomia e menores complicações, entretanto seu impacto na sobrevida do AEGJ é pouco conhecido. Objetivos: Comparar a esofagectomia por via transtorácica por toracoscopia (grupo A) com esofagectomia por via transhiatal (grupo B) em pacientes com AJEG em relação a ocorrência de complicações e mortalidade; número de linfonodos ressecados, acometidos e relação ressecados e acometidos; sobrevidas global e livre de doença; e sobrevida após recidiva. Métodos: Foram selecionados 147 pacientes entre 2000 e 2016. Cento e trinta (88%) do sexo masculino, média de idade de 64 anos. Os dados epidemiológicos (idade, sexo, índice de massa corpórea, ECOG e antecedentes pessoais) foram avaliados e comparados entre os grupos. As complicações pós-operatórias (fistula cervical, quilotorax, complicações respiratórias, rouquidão e infecções cirúrgicas) foram avaliadas. O estadiamento anátomo-patológico foi avaliado pela 7a. edição AJCC, analisando os linfonodos ressecados, acometidos e a relação de ressecados e acometidos. Foram feitas análises da sobrevivência global, livre de doença, e após recidiva; além de análise multivariada de fatores relacionados à sobrevida. Resultados: Em relação aos dados epidemiológicos, o grupo A apresentava uma média de idade de 61,1 anos e grupo B, de 65,7 anos (p=0,009). Dos 54 pacientes do grupo A, 47 (87,0%) foram submetidos a tratamento neoadjuvante, contra 43 (46,3%) dos 93 pacientes do grupo B (p < 0,001). Em relação às complicações, o grupo A apresentou maior ocorrência de rouquidão e infecções cirúrgicas. Em relação à mortalidade, o grupo A apresentou dois casos (3,7%) e grupo B apresentou quatro (4,3%), sem diferença estatística. Não houve diferença estatística entre os grupos A e B quanto à localização topográfica do tumor, grau histológico, pT, pN, estádio, extensão do tumor, invasão linfática, venosa e perineural. No grupo A, a média de linfonodos ressecados foi 31,88 linfonodos e no grupo B 20,73 linfonodos (p < 0,001); entretanto a média de linfonodos acometidos no grupo A foi 3,96 linfonodos e no grupo B 4,25 linfonodos, sem diferença estatística, bem como a razão ressecados acometidos. A sobrevida global geral foi 42,3%, nos grupo A, 38,9% e no grupo B, 7,6% (p=0,298). Na análise multivariada da sobrevida global somente a invasão linfática (p=0,005), diabetes mellitus (p=0,038) e infecção cirúrgica (p=0,001) foram significantes. A sobrevida livre de doença geral foi 45,6%, no grupo A 40% e grupo B 46% (p=0,77) e, na multivariada, somente a invasão linfática (p=0,01) e o diabetes mellitus (p=0,049) foram significantes. Entretanto nos tumores com estádio até 2B a sobrevida global do grupo A foi 80,4% e do grupo B, 38,5% (p=0,001). A sobrevida após recidiva foi melhor na recidiva pulmonar, seguida pela hepática ou mediastinal e peritoneal (p=0,001). Conclusão: Ambos os métodos são seguros com taxas de morbidade e mortalidade semelhantes. A esofagectomia por toracoscopia permite uma ressecção maior do número de linfonodos. As sobrevidas globais e livres de doença são semelhantes, entretanto até o estádio 2B a esofagectomia por toracoscopia melhora a sobrevida global. Diabetes e invasão linfática interferem na sobrevida global e livre de doença / The surgical treatment of adenocarcinoma of the esophagogastric junction surgical treatment (AGEJ) is still controversial, particularly concerning to survival and postoperative complications. With the advent of minimally invasive surgery and thoracoscopy, there has been an increase in lymphadenectomy and less complications, however its impact on survival of AGEJ is still unknown. Objectives: To compare transthoracic thoracoscopic esophagectomy (group A) with transhiatal esophagectomy (group B) in patients with AGEJ in relation to the occurrence of complications and mortality; number of ressected lymph nodes, the positive and the ratio between the ressected and positive; overall and disease free survival; and survival after relapse. Methods: There was a selection of 147 patients from 2000 to 2016. One hundred and thirty (88%) were male, the average age was 64 years old. Epidemiological data (age, sex, body mass index, ECOG and past medical history) were analyzed and compared between the groups. Postoperative complications (cervical fistulae, chylothorax, respiratory complications, hoarseness and surgical infections) were evaluated. The anatomopathological staging was evaluated by the 7th UICC edition, analyzing the resected lymph nodes, the affected and the ratio between the resected and affected. Analysis of overall survival, disease free survival and survival after relapse were made, besides multivariate analysis of survival related factors. Results: In relation to the epidemiological data, group A presented an average age of 61.1 years, and group B of 65.7 years (p=0.009). 47 (87.0%) of the 54 patients in group A were submitted to neoadjuvant treatments, against 43 (46.3%) of the 93 patients in group B (p < 0.001). In relation to the complications, group A presented greater occurrence of hoarseness and surgical infections. In relation to mortality, group A presented 2 cases (3.7%) and group B presented 4 (4.3%), without statistical difference. There was no statistical difference between groups A and B about topographic location of the tumor, histologic grade, pT, pN, stage, tumor extension, lymphatic, venous or perineural invasion. In group A, the average number of ressected lymph nodes was 31.88 and in group B was 20.73 (p < 0.001), however the average number of affected lymph nodes was 3.96 in group A and 4.25 in group B, without statistical difference, as well as the ratio between ressected and affected lymph nodes. The general overall survival was 42.3%, in group A was 38.9% and in group B was 47.6% (p=0.298). In the multivariate analysis of overall survival only lymphatic invasion (p=0.005), diabetes mellitus (p=0.038) and surgical infection (p- 0.001) were significant. The general disease free survival was 45.6%, in group A was 40% and in group B was 46% (p=0.77) and in multivariate analysis only lymphatic invasion (p=0.01) and diabetes mellitus (p=0.049) were significant. However, in tumors with stage until 2B, group A overall survival was 80.4% and group B was 38.5% (p=0.001). Survival after relapse was better in pulmonary relapse, followed by hepatic or mediastinal and peritoneal (p=0.001). Conclusion: Both methods are safe with similar morbidity and mortality rates. Transthoracic thoracoscopic esophagectomy allows a larger ressection in the number of lymph nodes. Overall survival and disease free survival are similar, however until stage 2B thoracoscopic esophagectomy improves overall survival. Diabetes and lymphatic invasion interfere in overall and disease free survival

O tratamento cirúrgico do adenocarcinoma da junção esofagogástrica (AJEG) ainda é controverso, particularmente, em relação à sobrevida e complicações pós-operatórias. Com o advento da cirurgia minimamente invasiva e toracoscopia, houve um aumento da linfadenectomia e menores complicações, entretanto seu impacto na sobrevida do AEGJ é pouco conhecido. Objetivos: Comparar a esofagectomia por via transtorácica por toracoscopia (grupo A) com esofagectomia por via transhiatal (grupo B) em pacientes com AJEG em relação a ocorrência de complicações e mortalidade; número de linfonodos ressecados, acometidos e relação ressecados e acometidos; sobrevidas global e livre de doença; e sobrevida após recidiva. Métodos: Foram selecionados 147 pacientes entre 2000 e 2016. Cento e trinta (88%) do sexo masculino, média de idade de 64 anos. Os dados epidemiológicos (idade, sexo, índice de massa corpórea, ECOG e antecedentes pessoais) foram avaliados e comparados entre os grupos. As complicações pós-operatórias (fistula cervical, quilotorax, complicações respiratórias, rouquidão e infecções cirúrgicas) foram avaliadas. O estadiamento anátomo-patológico foi avaliado pela 7a. edição AJCC, analisando os linfonodos ressecados, acometidos e a relação de ressecados e acometidos. Foram feitas análises da sobrevivência global, livre de doença, e após recidiva; além de análise multivariada de fatores relacionados à sobrevida. Resultados: Em relação aos dados epidemiológicos, o grupo A apresentava uma média de idade de 61,1 anos e grupo B, de 65,7 anos (p=0,009). Dos 54 pacientes do grupo A, 47 (87,0%) foram submetidos a tratamento neoadjuvante, contra 43 (46,3%) dos 93 pacientes do grupo B (p < 0,001). Em relação às complicações, o grupo A apresentou maior ocorrência de rouquidão e infecções cirúrgicas. Em relação à mortalidade, o grupo A apresentou dois casos (3,7%) e grupo B apresentou quatro (4,3%), sem diferença estatística. Não houve diferença estatística entre os grupos A e B quanto à localização topográfica do tumor, grau histológico, pT, pN, estádio, extensão do tumor, invasão linfática, venosa e perineural. No grupo A, a média de linfonodos ressecados foi 31,88 linfonodos e no grupo B 20,73 linfonodos (p < 0,001); entretanto a média de linfonodos acometidos no grupo A foi 3,96 linfonodos e no grupo B 4,25 linfonodos, sem diferença estatística, bem como a razão ressecados acometidos. A sobrevida global geral foi 42,3%, nos grupo A, 38,9% e no grupo B, 7,6% (p=0,298). Na análise multivariada da sobrevida global somente a invasão linfática (p=0,005), diabetes mellitus (p=0,038) e infecção cirúrgica (p=0,001) foram significantes. A sobrevida livre de doença geral foi 45,6%, no grupo A 40% e grupo B 46% (p=0,77) e, na multivariada, somente a invasão linfática (p=0,01) e o diabetes mellitus (p=0,049) foram significantes. Entretanto nos tumores com estádio até 2B a sobrevida global do grupo A foi 80,4% e do grupo B, 38,5% (p=0,001). A sobrevida após recidiva foi melhor na recidiva pulmonar, seguida pela hepática ou mediastinal e peritoneal (p=0,001). Conclusão: Ambos os métodos são seguros com taxas de morbidade e mortalidade semelhantes. A esofagectomia por toracoscopia permite uma ressecção maior do número de linfonodos. As sobrevidas globais e livres de doença são semelhantes, entretanto até o estádio 2B a esofagectomia por toracoscopia melhora a sobrevida global. Diabetes e invasão linfática interferem na sobrevida global e livre de doença / The surgical treatment of adenocarcinoma of the esophagogastric junction surgical treatment (AGEJ) is still controversial, particularly concerning to survival and postoperative complications. With the advent of minimally invasive surgery and thoracoscopy, there has been an increase in lymphadenectomy and less complications, however its impact on survival of AGEJ is still unknown. Objectives: To compare transthoracic thoracoscopic esophagectomy (group A) with transhiatal esophagectomy (group B) in patients with AGEJ in relation to the occurrence of complications and mortality; number of ressected lymph nodes, the positive and the ratio between the ressected and positive; overall and disease free survival; and survival after relapse. Methods: There was a selection of 147 patients from 2000 to 2016. One hundred and thirty (88%) were male, the average age was 64 years old. Epidemiological data (age, sex, body mass index, ECOG and past medical history) were analyzed and compared between the groups. Postoperative complications (cervical fistulae, chylothorax, respiratory complications, hoarseness and surgical infections) were evaluated. The anatomopathological staging was evaluated by the 7th UICC edition, analyzing the resected lymph nodes, the affected and the ratio between the resected and affected. Analysis of overall survival, disease free survival and survival after relapse were made, besides multivariate analysis of survival related factors. Results: In relation to the epidemiological data, group A presented an average age of 61.1 years, and group B of 65.7 years (p=0.009). 47 (87.0%) of the 54 patients in group A were submitted to neoadjuvant treatments, against 43 (46.3%) of the 93 patients in group B (p < 0.001). In relation to the complications, group A presented greater occurrence of hoarseness and surgical infections. In relation to mortality, group A presented 2 cases (3.7%) and group B presented 4 (4.3%), without statistical difference. There was no statistical difference between groups A and B about topographic location of the tumor, histologic grade, pT, pN, stage, tumor extension, lymphatic, venous or perineural invasion. In group A, the average number of ressected lymph nodes was 31.88 and in group B was 20.73 (p < 0.001), however the average number of affected lymph nodes was 3.96 in group A and 4.25 in group B, without statistical difference, as well as the ratio between ressected and affected lymph nodes. The general overall survival was 42.3%, in group A was 38.9% and in group B was 47.6% (p=0.298). In the multivariate analysis of overall survival only lymphatic invasion (p=0.005), diabetes mellitus (p=0.038) and surgical infection (p- 0.001) were significant. The general disease free survival was 45.6%, in group A was 40% and in group B was 46% (p=0.77) and in multivariate analysis only lymphatic invasion (p=0.01) and diabetes mellitus (p=0.049) were significant. However, in tumors with stage until 2B, group A overall survival was 80.4% and group B was 38.5% (p=0.001). Survival after relapse was better in pulmonary relapse, followed by hepatic or mediastinal and peritoneal (p=0.001). Conclusion: Both methods are safe with similar morbidity and mortality rates. Transthoracic thoracoscopic esophagectomy allows a larger ressection in the number of lymph nodes. Overall survival and disease free survival are similar, however until stage 2B thoracoscopic esophagectomy improves overall survival. Diabetes and lymphatic invasion interfere in overall and disease free survival